Trial intelligence / Profile preview

Momestasone in Rhinitis Medicamentosa

NCT04898764Phase 4Completed

Sponsor
Ghent University Hospital
Start
Oct 2020
Primary completion
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mometasone furoate nasal spray in rhinitis medicamentosa (RM), sponsored by Ghent University Hospital. Started Oct 2020; status: completed.

02

Drugs

mometasone furoate nasal spray
03

Conditions

rhinitis medicamentosa (RM)

Beyond the preview

Go deeper on NCT04898764.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04898764.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call